QUINOLONES AS INHIBITORS OF CLASS IV BROMODOMAIN PROTEINS

The present invention provides compounds of formula (I) as described herein and pharmaceutically acceptable salts, hydrates and solvates thereof for use in medicine, for example in the treatment of acute myeloid leukaemia: Cette invention concerne des composés de formule (I) tels que décrits dans la...

Full description

Saved in:
Bibliographic Details
Main Authors IGOE, NIALL, BAYLE, ELLIOTT DAVID, FISH, PAUL VINCENT
Format Patent
LanguageEnglish
French
Published 10.03.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides compounds of formula (I) as described herein and pharmaceutically acceptable salts, hydrates and solvates thereof for use in medicine, for example in the treatment of acute myeloid leukaemia: Cette invention concerne des composés de formule (I) tels que décrits dans la présente et des sels pharmaceutiquement acceptables, des hydrates et des solvates de ceux-ci destinés à être utilisés en médecine, par exemple pour traiter la leucémie myéloïde aiguë.
Bibliography:Application Number: WO2015EP69770